基础医学与临床 ›› 2024, Vol. 44 ›› Issue (2): 219-224.doi: 10.16352/j.issn.1001-6325.2024.02.0219

• 研究论文 • 上一篇    下一篇

奥美拉唑联合不同益生菌调节肠道菌群减轻小儿功能性消化不良

何昀1,2*, 肖力1, 曹娟1, 刘志刚1, 罗威耀1   

  1. 1.佛山市妇幼保健院 儿科,广东 佛山 528000;
    2.南方医科大学 第一临床医学院,广东 广州 510000
  • 收稿日期:2023-06-07 修回日期:2023-11-27 发布日期:2024-02-05
  • 通讯作者: *xuemei322@126.com
  • 基金资助:
    佛山市科学技术局自筹经费类科技创新项目(医学类科技攻关)(2220001004290)

Omeprazole combined with different probiotics regulates intestinal microbiota to alleviate functional dyspepsia in children

HE Yun1,2*, XIAO Li1, CAO Juan1, LIU Zhigang1, LUO Weiyao1   

  1. 1. Department of Pediatrics, Foshan Maternal and Child Health Hospital, Foshan 528000;
    2. the First Clinical College, Southern Medical University, Guangzhou 510000, China
  • Received:2023-06-07 Revised:2023-11-27 Published:2024-02-05
  • Contact: *xuemei322@126.com

摘要: 目的 探讨奥美拉唑联合不同益生菌调节肠道菌群减轻小儿功能性消化不良(FD)的作用。方法 选取佛山市妇幼保健院儿科2022年1月至2023年2月收治的200例FD患儿为研究对象,随机分为奥美拉唑组,奥美拉唑分别联合布拉氏酵母菌散组、酪酸梭菌二联活菌组和双歧杆菌四联活菌片组。治疗2周,对比各组患儿血清炎性因子、胃肠激素、肠道菌群、症状评分等指标变化。统计各组临床疗效及治疗期间不良反应发生率。结果 治疗后各组血清IL-6、TNF-α、IL-1β、超敏C反应蛋白(hs-CRP)、血管活性肠肽(VIP)、生长抑素(SS)水平、肠杆菌、肠球菌较治疗前显著下降(P<0.05),3个联合治疗组显著低于奥美拉唑组(P<0.05);治疗后各组血清胃动素(MOT)水平、双歧杆菌、乳杆菌显著升高(P<0.05),3个联合治疗组显著高于奥美拉唑组(P<0.05);治疗后各组症状评分较治疗前显著降低(P<0.05),3个联合治疗组显著低于奥美拉唑组(P<0.05);各组治疗期间不良反应发生率比较差异无统计学意义。结论 奥美拉唑联合不同益生菌在治疗小儿FD中均取得良好效果。

关键词: 奥美拉唑, 益生菌, 肠道菌群, 功能性消化不良

Abstract: Objective To explore the effect of omeprazole combined with different probiotics on regulating intestinal flora in reducing functional dyspepsia (FD) in children. Methods Two hundreds children with FD admitted to the Pediatric Department of Foshan Maternal and Child Health Hospital from January 2022 to February 2023 were selected as the study subjects. They were randomly divided into omeprazde(omep) group, groups of omeprazole +yeast(yeast group), +clostridium butyricum(clos group), and +bifidobacterium(bifi group) respectively. Results After treatment, serum level of IL-6, TNF-α, IL-1β, hs-CRP, VIP, SS, Enterobacter and Enterococcus in all groups significantly decreased as compared with the finding before treatment (P<0.05). Those targets in the three combined treatment groups were significantly lower compared to the ome group; After treatment, the serum MOT level,bifidobacteria, and lactobacilli in each group were significantly increased (P<0.05), and the results from three combined treatment groups demonstrated notably higher levels compared to the omep group(P<0.05); The scores of symptoms in all groups showed a significant alleviation after the treatment(P<0.05). Additionally, the three combined treatment groups exhibited significantly lower symptom scores than the group treated with omeprazole alone (P<0.05). There was no difference in the incidence of adverse reactions during treatment among the groups. Conclusions Omeprazole combined with different probiotics have achieved good results in the treatment of FD in children.

Key words: omeprazole, probiotics, intestinal flora, functional dyspepsia

中图分类号: